tiprankstipranks
AIM ImmunoTech Inc (AIM)
NYSE MKT:AIM

AIM ImmunoTech (AIM) Cash flow

812 Followers

AIM ImmunoTech Cash Flow

AIM's free cash flow for Q2 2023 was $-2.21M. For the 2023 fiscal year, AIM's free cash flow was decreased by $1.87M and operating cash flow was $-2.16M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -16.85M$ -16.11M$ -13.96M$ -10.37M$ -9.07M$ -10.64M
Investing Cash Flow
$ 3.33M$ 10.99M$ -631.00K$ -9.16M$ -6.15M$ 92.00K
Financing Cash Flow
$ 130.00K$ 80.00K$ 8.19M$ 56.56M$ 16.39M$ 9.44M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 98.17M$ 27.05M$ 32.09M$ 38.50M$ 1.47M$ 299.00K
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
-----$ 328.00K
Issuance Of Capital Stock
$ 130.00K$ 80.00K$ 13.04M$ 61.25M$ 15.30M$ 5.07M
Issuance Of Debt
--$ -122.00K$ 0.00$ 3.63M$ 7.14M
Repayment Of Debt
--$ -122.00K$ -4.68M$ -2.55M$ -2.22M
Free Cash Flow
$ -13.47M$ -12.48M$ -14.35M$ -10.96M$ -9.43M$ -10.77M
Domestic Sales
------
Foreign Sales
------
Currency in USD

AIM ImmunoTech Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis